Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial

Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:11:54.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for the clinical trial assessing the efficacy and safety of navarixin in combination with pembrolizumab in adults with selected advanced/metastatic solid tumors.
    Difference
    0.1%
    Check dated 2024-06-06T14:17:33.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for individuals with certain advanced/metastatic solid tumors (NSCLC, CRPC, or MSS CRC) and outlining specific health conditions and prior treatments required for inclusion.
    Difference
    48%
    Check dated 2024-05-22T20:54:09.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:48:31.000Z thumbnail image

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.